 Home > Active Ingredient News > Study of Nervous System > Stroke: The effect of lipid-lowering treatment target value on intracranial hemorrhage

Stroke: The effect of lipid-lowering treatment target value on intracranial hemorrhage

 Last Update: 2022-01-08
 Source: Internet
 Author: User

Tags

low flash point

dividend per share

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Although statin therapy has a secondary preventive effect on ischemic stroke , in some cases, statin therapy can increase the risk of intracranial hemorrhage .

Stroke prevention

Recently, the heart blood vessels published a research article on the disease areas prestigious journal Stroke, the objective of this lipid-lowering therapy in patients with stroke (TST) test, the researchers aimed for a pre-specified predictors of intracranial hemorrhage events were explored
.

Blood vessel

Patients with ischemic stroke in the past 3 months or transient ischemic attack in the past 15 days and evidence of cerebrovascular or coronary atherosclerosis will be randomly assigned to the low lipid-lowering treatment target at a ratio of 1:1 Density lipoprotein (LDL) cholesterol is less than 70mg/dL or 100±10mg/dL, and the lipid-lowering drugs used by the subjects are statins or ezetimibe
.

cholesterol

Among the 2860 patients included in the study, a total of 31 cases of intracranial hemorrhage occurred during a median follow-up of 3 years.
Per 1000 patients per year [95%CI 2.

38-4.

hypertension

It can be seen that, compared with the lipid-lowering treatment of 100±10mg/dL, controlling the LDL cholesterol of patients with atherosclerotic ischemic stroke to <70mg/dL does not significantly increase the risk of intracranial hemorrhage
.
Intracranial hemorrhage events are not related to lower LDL cholesterol levels

Compared with the lipid-lowering treatment of 100±10mg/dL, controlling the LDL cholesterol of patients with atherosclerotic ischemic stroke to <70mg/dL does not significantly increase the risk of intracranial hemorrhage

Original source:

Pierre Amarenco.

et al.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

High Quality Pregabalin 99% powder 148553-50-8 -Shaanxi Dideu Medichem Co.Ltd

CAS No.: 148553-50-8

Chemical Grade

$1/KG FOB

High Quality GMP USP Standard Gabapentin CAS 60142-96-3 with best price

CAS No.: 60142-96-3

Pharmacy Grade

$70-90/KG FOB

High Quality Trh Protirelin Peptide CAS 24305-27-9 Tsh-Releasing Hormone

CAS No.: 24305-27-9

Pharmacy Grade

$10-13/G FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.